Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: Position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005

Linda M. Griffith, Steven Z. Pavletic, Alan Tyndall, Christopher N. Bredeson, James D. Bowen, Richard W. Childs, Alois Gratwohl, Jacob M. van Laar, Maureen D. Mayes, Roland Martin, Peter A. McSweeney, Paolo A. Muraro, Harry Openshaw, Riccardo Saccardi, Brenda M. Sandmaier, Stephen J. Forman, Richard A. Nash, Joseph H. Antin, Michael R. Bishop, Christopher N. BredesonStephen J. Forman, Sergio Giralt, Ronald Gress, Chitra Hosing, Effie W. Petersdorf, Judith A. Shizuru, Keith Sullivan, John F. Tisdale, James D. Bowen, Jacqueline Chen, Hans Lassmann, Sridar Narayanan, Chiara Bocelli-Tyndall, Philip J. Clements, Daniel E. Furst, Gabor G. Illei, James D. McNamara, Barbara B. Mittleman, John O'Shea, Michael M. Ward

Research output: Contribution to journalArticlepeer-review

59 Scopus citations
Original languageEnglish (US)
Pages (from-to)862-870
Number of pages9
JournalBiology of Blood and Marrow Transplantation
Volume11
Issue number11
DOIs
StatePublished - Nov 1 2005

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Autoimmune disease
  • Clinical trial

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this